Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry

Pierre-Henry GABRIELLE; Vuong Nguyen; Jennifer J Arnold; David Squirrell; Louis Arnould; Jorge Sanchez-Monroy; Francesco Viola; Louise O’ Toole; Daniel Barthelmes; Catherine Creuzot-Garcher; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1344 – F0178. doi:

ARVO Annual Meeting Abstract June 2022

36-month outcomes of VEGF inhibitors for treatment-naïve Central Retinal Vein Occlusion: Data from the Fight Retinal Blindness! registry.

Adrian Hunt; Vuong Nguyen; Sanjeeb Bhandari; Jennifer J Arnold; Ian McAllister; Hemal Mehta; Alessandro Invernizzi; David Squirrell; Theodorus Ponsioen; Pierre-Henry GABRIELLE; Louise O’ Toole; Javier Zarranz-Ventura; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2674. doi:

Articles November 2021

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

PDF

Pierre-Henry Gabrielle; Vuong Nguyen; Jennifer J. Arnold; Sanjeeb Bhandari; Francesco Viola; Odette A. M. Tigchelaar-Besling; Gonzaga Garay-Aramburu; Louise O'Toole; Chui Ming Gemmy Cheung; Daniel Barthelmes; Catherine Creuzot-Garcher; Mark Gillies
TAGS: atrophoderma maculatum, exudative age-related macular degeneration, eye, fibrosis
Trans. Vis. Sci. Tech.. 2021; 10(13):5. doi: https://doi.org/10.1167/tvst.10.13.5

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Javier Zarranz-Ventura; Vuong Nguyen; Catherine P Creuzot Garcher; Frank D Verbraak; Louise OToole; Alessandro Invernizzi; Francesco Viola; David Squirrell; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):311. doi:

ARVO Annual Meeting Abstract June 2021

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Vuong Nguyen; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):455. doi:

ARVO Annual Meeting Abstract June 2021

Quality of life impact of eye diseases: a Save Sight Registries study

Himal Kandel; Vuong Nguyen; Mark C Gillies; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3495. doi:

Articles December 2020

Assessing Residual Cone Function in Retinitis Pigmentosa Patients

PDF

Tasneem A. Arsiwalla; Elisa E. Cornish; Phuc Vuong Nguyen; Maria Korsakova; Haipha Ali; Nonna Saakova; Clare L. Fraser; Robyn V. Jamieson; John R. Grigg

Trans. Vis. Sci. Tech.. 2020; 9(13):29. doi: https://doi.org/10.1167/tvst.9.13.29

ARVO Annual Meeting Abstract June 2020

Comparison of Standard versus Accelerated corneal collagen cross-linking for keratoconus: one-year outcomes from Save Sight Keratoconus Registry study

Himal Kandel; Vuong Nguyen; Alex Ferdi; Aanchal Gupta; Marco Abbondanza; Laurence Sullivan; Andrew Apel; Richard A Mills; Jern Yee Chen; Adam Watson; Constantinos Petsoglou; Nicholas Downie; Stephanie Watson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3570. doi:

ARVO Annual Meeting Abstract June 2020

Who is getting clinically significant haze after Corneal Crossolinking for Keratoconus? A Save Sight Keratoconus Registry study

Stephanie Watson; Himal Kandel; Alex Ferdi; Vuong Nguyen; Aanchal Gupta; Marco Abbondanza; Laurence Sullivan; Andrew Apel; Richard A Mills; Jern Y Chen; Adam Watson; Constantinos Petsoglou; Nicholas Downie

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4067. doi:

ARVO Annual Meeting Abstract June 2020

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Mark C Gillies; Vuong Nguyen; Calvo Pilar; Martin Puzo; Pierre-Henry GABRIELLE; Catherine P Creuzot Garcher; Florian Baudin; Benjamin Wolff; Louise O’ Toole; Laurent Castelnovo; Michel Guillaume; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4214. doi:

ARVO Annual Meeting Abstract June 2020

Electrophysiological Assessment in Birdshot Chorioretinopathy: Use of a Portable Device in the Clinic

Anna Michelle Waldie; Angharad E Hobby; Isabelle Chow; Elisa Eleanor Cornish; Mathura Indusegaran; Alexandra Pekacka; Vuong Nguyen; Clare Fraser; Alison M Binns; Miles R. Stanford; Christopher Hammond; Peter J McCluskey; John R Grigg; Omar Mahroo

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5045. doi:

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289. doi:

ARVO Annual Meeting Abstract June 2020

5-year outcomes of corneal cross-linking: A Save Sight Keratoconus Registry study

Alex Ferdi; Vuong Nguyen; Himal Kandel; Jeremy Tan; Francisco Arnalich Montiel; Marco Abbondanza; Stephanie Watson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2339. doi:

ARVO Annual Meeting Abstract July 2019

Assessing residual cone function in Retinitis Pigmentosa: electrophysiological and optical coherence tomography findings and correlation with visual acuity

Tasneem Arsiwalla; Elisa Eleanor Cornish; Vuong Nguyen; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4525. doi:

ARVO Annual Meeting Abstract July 2019

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

SANJEEB BHANDARI; Anne Catherine Biechl; Jennifer Joan Arnold; Stephanie Young; Samanta Fraser-Bell; Hemal Mehta; Mark C Gillies; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2602. doi:

ARVO Annual Meeting Abstract July 2019

Twenty-four month outcomes of inflammatory choroidal neovascularization treated with intravitreal anti vascular endothelial growth factors: a comparison between two treatment regimens

Alessandro Invernizzi; Francesco Pichi; Richard Symes; Sophia Zagora; Vuong Nguyen; Stefano Erba; Alba Xhepa; Luca De Simone; Luca Cimino; Mark C Gillies; Peter J McCluskey

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3859. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Sarah Ah-Moye; Pardis Zalmay; Magnus Theodorsson; Martin Lynn Harris; Riaz Asaria; Adrian Hunt; Daniel Barthelmes; Mark C Gillies; Vuong Nguyen; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4061. doi:

ARVO Annual Meeting Abstract July 2019

Implementing the Save Sight Keratoconus Registry in the hospital setting

Alex Ferdi; Vuong Nguyen; Chameen Samarawickrama; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5455. doi:

ARVO Annual Meeting Abstract July 2019

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Mark C Gillies; SANJEEB BHANDARI; Benjamin Wolff; Jennifer Joan Arnold; Rohan W Essex; Stephanie Young; David M Squirrell; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):111. doi:

ARVO Annual Meeting Abstract July 2019

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

Vuong Nguyen; Anagha Vaze; Samanta Fraser-Bell; Jennifer Joan Arnold; Rohan W Essex; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):139. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry

36-month outcomes of VEGF inhibitors for treatment-naïve Central Retinal Vein Occlusion: Data from the Fight Retinal Blindness! registry.

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Quality of life impact of eye diseases: a Save Sight Registries study

Assessing Residual Cone Function in Retinitis Pigmentosa Patients

Comparison of Standard versus Accelerated corneal collagen cross-linking for keratoconus: one-year outcomes from Save Sight Keratoconus Registry study

Who is getting clinically significant haze after Corneal Crossolinking for Keratoconus? A Save Sight Keratoconus Registry study

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Electrophysiological Assessment in Birdshot Chorioretinopathy: Use of a Portable Device in the Clinic

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

5-year outcomes of corneal cross-linking: A Save Sight Keratoconus Registry study

Assessing residual cone function in Retinitis Pigmentosa: electrophysiological and optical coherence tomography findings and correlation with visual acuity

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

Twenty-four month outcomes of inflammatory choroidal neovascularization treated with intravitreal anti vascular endothelial growth factors: a comparison between two treatment regimens

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Implementing the Save Sight Keratoconus Registry in the hospital setting

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

To View More...

You must be signed into an individual account to use this feature.